These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31197658)

  • 1. Relationship of oral conditions to the incidence of infective endocarditis in periodontitis patients with valvular heart disease: a cross-sectional study.
    Ninomiya M; Hashimoto M; Yamanouchi K; Fukumura Y; Nagata T; Naruishi K
    Clin Oral Investig; 2020 Feb; 24(2):833-840. PubMed ID: 31197658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontitis is associated with incidental valvular heart disease: A nationwide population-based cohort study.
    Sia SK; Jan MS; Wang YH; Huang YF; Wei JC
    J Clin Periodontol; 2021 Aug; 48(8):1085-1092. PubMed ID: 34060116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronological changes in the annual incidence of valvular heart disease based on autopsies performed in Japan].
    Kawano H; Hisaoka T; Okada R
    J Cardiol; 1993; 23(4):359-63. PubMed ID: 8064585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.
    Pant S; Patel NJ; Deshmukh A; Golwala H; Patel N; Badheka A; Hirsch GA; Mehta JL
    J Am Coll Cardiol; 2015 May; 65(19):2070-6. PubMed ID: 25975469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.
    Iossa D; Molaro R; Andini R; Parrella A; Ursi MP; Mattucci I; De Vincentiis L; Dialetto G; Utili R; Durante-Mangoni E
    Medicine (Baltimore); 2016 Sep; 95(39):e4972. PubMed ID: 27684846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of immune complexes in patients with acquired valvular heart disease.
    Petelenz T; Kozioł M; Friedek D; Słomińska-Petelenz T; Trzeciak J; Drazkiewicz U; Tustanowski J; Nolewajka E; Elertowicz M
    Cor Vasa; 1988; 30(4):263-71. PubMed ID: 3168482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dentigenous infectious foci - a risk factor of infective endocarditis.
    Wisniewska-Spychala B; Sokalski J; Grajek S; Jemielity M; Trojnarska O; Choroszy-Krol I; Sójka A; Maksymiuk T
    Med Sci Monit; 2012 Feb; 18(2):CR93-104. PubMed ID: 22293883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
    Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
    Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Turkish registry of heart valve disease.
    Demirbağ R; Sade LE; Aydın M; Bozkurt A; Acartürk E
    Turk Kardiyol Dern Ars; 2013 Jan; 41(1):1-10. PubMed ID: 23518931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
    Coffey S; Cox B; Williams MJ
    Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes.
    Abbott KC; Hshieh P; Cruess D; Agodoa LY; Welch PG; Taylor AJ; Yuan CM
    Clin Nephrol; 2003 Feb; 59(2):79-87. PubMed ID: 12608550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves.
    Pericart L; Bernard A; Bourguignon T; Bernard L; Angoulvant D; Clementy N; Babuty D; Fauchier L
    Am J Cardiol; 2017 Jun; 119(11):1854-1861. PubMed ID: 28390684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infective endocarditis without biological inflammatory syndrome: Description of a particular entity.
    Ribeyrolles S; Ternacle J; San S; Lepeule R; Moussafeur A; Faivre L; Nahory L; Huguet R; Gallien S; Decousser JW; Fihman V; Fiore A; Mongardon N; Lim P; Oliver L
    Arch Cardiovasc Dis; 2019; 112(6-7):381-389. PubMed ID: 31303461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.